Encompass Health EVP has shares withheld for taxes

Encompass Health Corp executive John Patrick Darby reported routine tax-related share dispositions.

Rhea-AI Filing Summary

Encompass Health Corp executive John Patrick Darby reported routine tax-related share dispositions. On February 19, 2026 and February 20, 2026, a total of 8,231 shares of Encompass Health common stock were withheld or surrendered to cover tax withholding obligations from vesting restricted stock. These transactions, coded “F,” reflect tax-withholding dispositions rather than open-market sales, and Darby continued to hold 91,353 shares directly after the most recent transaction.

Insider Trade Summary

Exercise Price or Tax Liability: 8,231 shares

Exercise Price or Tax Liability 2 txns

Insider Darby John Patrick

Role EVP, Gen Counsel & Secretary

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	328	$106.55	$35K
Exercise Price or Tax Liability	Encompass Health Common Stock	7,903	$107.15	$847K

Holdings After Transaction: Encompass Health Common Stock — 91,353 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) report for John Patrick Darby?

Encompass Health reported that EVP and General Counsel John Patrick Darby had 8,231 shares withheld or surrendered for taxes. These Form 4 transactions covered tax obligations tied to vesting restricted stock, not discretionary open-market sales of Encompass Health common shares.

Were the Encompass Health (EHC) Form 4 transactions open-market sales?

No, the Form 4 transactions were not open-market sales. They were tax-withholding dispositions, where shares were withheld or surrendered to satisfy Darby’s tax obligations arising from vesting restricted stock awards, as indicated by transaction code F and the accompanying footnote.

How many Encompass Health (EHC) shares were used for tax withholding?

A total of 8,231 Encompass Health common shares were used for tax withholding. This consisted of 7,903 shares on February 19, 2026 and 328 shares on February 20, 2026, all tied to taxes from vesting restricted stock awards.

How many Encompass Health (EHC) shares does John Patrick Darby hold after these transactions?

After the reported tax-withholding dispositions, John Patrick Darby directly holds 91,353 Encompass Health common shares. This post-transaction balance reflects his ownership following the February 20, 2026 withholding related to vesting restricted stock awards.

What does transaction code F mean in the Encompass Health (EHC) Form 4?

Transaction code F on the Encompass Health Form 4 indicates payment of an exercise price or tax liability by delivering securities. Here, it reflects shares withheld or surrendered to satisfy Darby’s tax withholding obligations from vesting restricted stock awards, rather than voluntary market sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 03:36 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Darby John Patrick

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Gen Counsel & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/19/2026		F		7,903(1)	D	$107.15	91,681	D
Encompass Health Common Stock	02/20/2026		F		328(1)	D	$106.55	91,353	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	Patrick Darby	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.